Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Total Debt (2016 - 2025)

Nutex Health's Total Debt history spans 11 years, with the latest figure at $29.9 million for Q4 2025.

  • For Q4 2025, Total Debt fell 18.85% year-over-year to $29.9 million; the TTM value through Dec 2025 reached $29.9 million, down 18.85%, while the annual FY2025 figure was $29.9 million, 18.85% down from the prior year.
  • Total Debt for Q4 2025 was $29.9 million at Nutex Health, down from $30.9 million in the prior quarter.
  • Across five years, Total Debt topped out at $78.9 million in Q4 2021 and bottomed at $256352.0 in Q3 2021.
  • The 5-year median for Total Debt is $30.4 million (2025), against an average of $27.9 million.
  • The largest annual shift saw Total Debt surged 52496.03% in 2021 before it plummeted 67.46% in 2022.
  • A 5-year view of Total Debt shows it stood at $78.9 million in 2021, then tumbled by 67.46% to $25.7 million in 2022, then rose by 15.63% to $29.7 million in 2023, then grew by 24.17% to $36.9 million in 2024, then fell by 18.85% to $29.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Total Debt are $29.9 million (Q4 2025), $30.9 million (Q3 2025), and $39.4 million (Q2 2025).